(S)-Carisbamate-13C,15N,d2

• CAT Number: R013511
• CAS Number: 1246817-83-3
• Molecular Formula: C₈¹³CH₈D₂Cl¹⁵NO₃
• Molecular Weight: 219.63
• Purity: ≥95%
• Synonyms: (1S)-1-(2-Chlorophenyl)-1,2-ethanediol 2-Carbamate-13C,15N,d2; JNJ 10234094-13C,15N,d2; RWJ 333369-13C,15N,d2; YKP 509-13C,15N,d2
• Storage: -20°C
• IUPAC Name: [(2S)-2-(2-chlorophenyl)-1,1-dideuterio-2-hydroxyethyl] carbamate
• InChI: InChI=1S/C9H10ClNO3/c10-7-4-2-1-3-6(7)8(12)5-14-9(11)13/h1-4,8,12H,5H2,(H2,11,13)/t8-/m1/s1/i5D2,9+1,11+1
• InChIKey: OLBWFRRUHYQABZ-RXUIAGAKSA-N
• SMILES: [2H]C([2H])([C@H](C1=CC=CC=C1Cl)O)O[13C](=O)[15NH2]

(S)-Carisbamate-13C,15N,d2 is a stable isotope-labeled version of (S)-carisbamate, a compound used primarily in neurological research for its potential as an antiepileptic and neuroprotective agent. The incorporation of carbon-13, nitrogen-15, and two deuterium atoms allows for enhanced tracking and detailed analysis of the compound’s behavior in biological systems. This isotopic labeling aids in studying the drug’s pharmacokinetics, including its absorption, distribution, metabolism, and excretion (ADME), as well as in elucidating its mechanism of action through techniques such as NMR spectroscopy and mass spectrometry. This compound is crucial for optimizing therapeutic strategies and understanding the drug’s interactions and effects.